Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy
Open Access
- 2 October 2020
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 15 (1) , 1-10
Abstract
Purpose: Proton pencil beam scanning (PBS) represents an interesting option for the treatment of breast cancer (BC) patients with nodal involvement. Here we compare tangential 3D-CRT and VMAT to PBS proton therapy (PT) in terms of secondary cancer risk (SCR) for the lungs and for contralateral breast. Methods: Five BC patients including supraclavicular (SVC) nodes in the target (Group 1) and five including SVC plus internal-mammary-nodes (IMNs, Group 2) were considered. The Group 1 patients were planned by PT versus tangential 3D-CRT in free-breathing (FB). The Group 2 patients were planned by PT versus VMAT considering both FB and deep-inspiration breath hold (DIBH) irradiation. The prescription dose to the target volume was 50 Gy (2 Gy/fraction). A constant RBE = 1.1 was assumed for PT. The SCR was evaluated with the excess absolute risk (EAR) formalism, considering also the age dependence. A cumulative EAR was finally computed. Results: According to the linear, linear-exponential and linear-plateau dose response model, the cumulative EAR for Group 1 patients after PT was equal to 45 ± 10, 17 ± 3 and 15 ± 3, respectively. The corresponding relative increase for tangential 3D-CRT was equal to a factor 2.1 ± 0.5, 2.1 ± 0.4 and 2.3 ± 0.4. Group 2 patients showed a cumulative EAR after PT in FB equal to 65 ± 3, 21 ± 1 and 20 ± 1, according to the different models; the relative risk obtained with VMAT increased by a factor 3.5 ± 0.2, 5.2 ± 0.3 and 5.1 ± 0.3. Similar values emerge from DIBH plans. Contrary to photon radiotherapy, PT appears to be not sensitive to the age dependence due to the very low delivered dose. Conclusions: PBS PT is associated to significant SCR reduction in BC patients compared to photon radiotherapy. The benefits are maximized for young patients with both SVC and IMNs involvement. When combined with the improved sparing of the heart, this might contribute to the establishment of effective patient-selection criteria for proton BC treatments.Keywords
Funding Information
- Istituto Nazionale di Fisica Nucleare (MoVe IT Call CSN5)
This publication has 43 references indexed in Scilit:
- Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patientsRadiotherapy and Oncology, 2013
- TOPAS: An innovative proton Monte Carlo platform for research and clinical applicationsMedical Physics, 2012
- Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapyTheoretical Biology and Medical Modelling, 2011
- Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverageActa Oncologica, 2010
- Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary NodesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Effect of Intensity-Modulated Pelvic Radiotherapy on Second Cancer Risk in the Postoperative Treatment of Endometrial and Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998Radiation Research, 2007
- The use of risk estimation models for the induction of secondary cancers following radiotherapyActa Oncologica, 2005
- RBE-LET relationships for cell inactivation and mutation induced by low energy protons in V79 cells: further results at the LNL facilityInternational Journal of Radiation Biology, 1998
- Cancer in the Contralateral Breast after Radiotherapy for Breast CancerNew England Journal of Medicine, 1992